Little information is available for adult T-ALL cohorts and shows that the percentage of CDKN2B gene promoter methylation varies from 16% to 49%, and is 1% for the CDKN2A promoter (Table 4). The gene discussed is CDKN2B; the disease is acute lymphoblastic leukemia.